These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 34172073)
1. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy. Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073 [TBL] [Abstract][Full Text] [Related]
2. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy. Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB Front Immunol; 2020; 11():997. PubMed ID: 32508844 [TBL] [Abstract][Full Text] [Related]
3. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds? Fei L; Ren X; Yu H; Zhan Y Front Immunol; 2021; 12():771210. PubMed ID: 34804061 [TBL] [Abstract][Full Text] [Related]
4. CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis. Xu J; Ganguly A; Zhao J; Ivey M; Lopez R; Osterholzer JJ; Cho CS; Olszewski MA mBio; 2021 Aug; 12(4):e0107621. PubMed ID: 34311579 [TBL] [Abstract][Full Text] [Related]
5. Blockade of CCL2/CCR2 signaling pathway prevents inflammatory monocyte recruitment and attenuates OVA-Induced allergic asthma in mice. Jiang S; Wang Q; Wang Y; Song X; Zhang Y Immunol Lett; 2019 Oct; 214():30-36. PubMed ID: 31454522 [TBL] [Abstract][Full Text] [Related]
7. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442 [TBL] [Abstract][Full Text] [Related]
8. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900 [TBL] [Abstract][Full Text] [Related]
9. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345 [TBL] [Abstract][Full Text] [Related]
10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628 [TBL] [Abstract][Full Text] [Related]
11. Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury. Xu P; Zhang F; Chang MM; Zhong C; Sun CH; Zhu HR; Yao JC; Li ZZ; Li ST; Zhang WC; Sun GD J Neuroinflammation; 2021 Mar; 18(1):64. PubMed ID: 33653377 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148 [TBL] [Abstract][Full Text] [Related]
14. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus. Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963 [TBL] [Abstract][Full Text] [Related]
15. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760 [TBL] [Abstract][Full Text] [Related]
16. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches. Moadab F; Khorramdelazad H; Abbasifard M Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247 [TBL] [Abstract][Full Text] [Related]
17. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes. Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136 [TBL] [Abstract][Full Text] [Related]
18. The innate immune response to lower respiratory tract E. Coli infection and the role of the CCL2-CCR2 axis in neonatal mice. McGrath-Morrow SA; Ndeh R; Collaco JM; Poupore AK; Dikeman D; Zhong Q; Singer BD; D'Alessio F; Scott A Cytokine; 2017 Sep; 97():108-116. PubMed ID: 28628889 [TBL] [Abstract][Full Text] [Related]